SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-008167
Filing Date
2019-08-14
Accepted
2019-08-14 16:02:49
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20190630x10q.htm 10-Q 1810007
2 EX-31.1 ymab-20190630ex311743ba9.htm EX-31.1 20164
3 EX-31.2 ymab-20190630ex31298538e.htm EX-31.2 20062
4 EX-32.1 ymab-20190630ex32159781e.htm EX-32.1 9833
5 EX-32.2 ymab-20190630ex3223d61dd.htm EX-32.2 9791
  Complete submission text file 0001558370-19-008167.txt   4912586

Data Files

Seq Description Document Type Size
6 EX-101.INS ymab-20190630.xml EX-101.INS 672316
7 EX-101.SCH ymab-20190630.xsd EX-101.SCH 45909
8 EX-101.CAL ymab-20190630_cal.xml EX-101.CAL 37877
9 EX-101.DEF ymab-20190630_def.xml EX-101.DEF 136525
10 EX-101.LAB ymab-20190630_lab.xml EX-101.LAB 359366
11 EX-101.PRE ymab-20190630_pre.xml EX-101.PRE 294177
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 191026134
SIC: 2834 Pharmaceutical Preparations